
Scholar Rock Holding Corporation
Scholar Rock Holding Corporation (SRRK) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · SRRK · as of Jun 9, 2026
Key Statistics
Explore Scholar Rock Holding Corporation Data
srrk stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 12 · Buy rate: 100.0%
The SRRK analyst consensus is Buy, based on ratings from 12 Wall Street analysts over the past 3 months. The average 12-month price target is $59.17, representing +35.09% upside from the current price of $43.80.
Competitors & Peers
srrk competitorsStock Performance
Full HistoryAbout Scholar Rock Holding Corporation
Scholar Rock Holding Corporation is a biopharmaceutical firm dedicated to discovering and advancing treatments for severe medical conditions by targeting the crucial role of protein growth factor sign…
what is scholar rock holding corporation · srrk stock overview · scholar rock holding corporation company profile · who is scholar rock holding corporation ceo · srrk NASDAQ · scholar rock holding corporation headquarters · scholar rock holding corporation business segments
About Stock Overview & Key Data
Scholar Rock Holding Corporation (SRRK) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since May 25, 2018. As of the latest trading session, SRRK stock price is $43.80, with a market capitalization of $5.2B. The stock has returned +28.56% over the past 12 months and -0.57% year-to-date.
According to 12 Wall Street analysts, the consensus rating for Scholar Rock Holding Corporation stock is Buy, with an average 12-month price target of $59.17. In fiscal year 2025, Scholar Rock Holding Corporation reported revenue of — and net income of -$377.9M. For detailed data — including Scholar Rock Holding Corporation revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Scholar Rock Holding Corporation (SRRK) stock price is $43.80. The stock is traded on NASDAQ under the ticker symbol SRRK. The 52-week range is $27.07 – $52.19.